BI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment
Clinical trial NCT02672852 · COMPLETED
Trial details
- NCT number
- NCT02672852
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-29
- Primary completion
- 2017-08-02
- Enrollment
- 507
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.